Cerbios-Pharma returns to DCAT Week in NYC

news-releasesCERBIOS-PHARMA SA
March 10th 2022

Lugano, Switzerland: – Pharmaceutical ingredient specialist Cerbios-Pharma SA (Cerbios) will once again be a high-profile presence at this year’s DCAT Week 2022 in New York City.

Cerbios will take two suites at the Lotte New York Palace Hotel to support its networking with current and prospective customers that are central to its participation in DCAT week.

Cerbios has been a longtime supporter of the event and will send a strong team to New York City to mark the return of DCAT week as a face-to-face gathering there.

Cerbios team  

The team will include Valentino Mandell, M&S Manager for the Cerbios Products Portfolio, and high potency active ingredient (HPAPI) CDMO services, Vitor Sousa, responsible for Business Development in antibody drug conjugates (ADCs) and Biotechnology, and Chief Commercial Officer Denis Angioletti.

Together, they will present Cerbios-Pharma’s latest advances in GMP manufacturing of HPAPIs, monoclonal antibodies (mAbs), reduced folates, Vitamin D derivatives, and respiratory, dermatology, oncology, and cytotoxic products, as well as its PROVEO division for end-to-end one stop shop ADC production.

About Cerbios-Pharma

Cerbios is a privately held company located in Lugano, Switzerland, specialized in manufacturing Pharma Products and in offering CDMO services.

Cerbios is a global leading supplier of a portfolio of Generic APIs primarily used in Oncology and for the treatment of Respiratory and Dermatological disorders. Cerbios has additionally a 40 years’ experience in the probiotics field: the portfolio includes a FDF based on proprietary strain SF68® for treatment of diarrhea and dysbiosis by antibiotics and two new Food Supplements for the management of ACNE & Seborrheic dermatitis and to boost immune response.

Cerbios is also the ideal CDMO partner from clinical to commercial supply of API, HPAPIs, Payloads, ADCs, Proteins and Antibodies. Services offered include Process & Analytical Development, Scale-up and Clinical Supply, Industrial Validation, Commercial Supply, Full CMC Regulatory Support. Proveo (TM) is a Cerbios division recently created to provide end-to-end development and manufacturing services for ADCs.

Learn more at: https://cerbios.swiss

About DCAT Week 2022

The Drug, Chemical & Associated Technologies Association (DCAT), founded in 1890, has become North America’s premier business development association for companies that manufacture, distribute or provide services to the pharmaceutical and chemical industries.

DCAT represents the entire spectrum of the pharmaceutical industry—from pharmaceutical, API, and excipient sales and manufacturing to distribution, support technologies and packaging products and services.

Attended by thousands of industry professionals, DCAT Week® and the DCAT Annual Dinner, held each March in New York City, is considered as a premier global event for companies engaged in the biotech and pharmaceutical manufacturing value chains.

DCAT Week 2022 will take place over four days from March 21 to March 24. The Waldorf Astoria is restored to its traditional place as headquarters for the event, with activities shared between several other downtown hotels including the Lotte New York Palace, Omni Berkshire Place, 48LEX, Benjamin and InterContinental Barclay, with the 94th DCAT Annual Dinner held in the Grand Ballroom of the New York Hilton on Thursday, March 24.

The event is returning as a face to face gathering after a hiatus during 2020 and 2021, due to the COVID-19 pandemic. This year’s event is being hosted in strict compliance with New York State health and safety protocols, including proof of vaccination.

The event is organized by DCAT with more information at: https://dcatweek.org


Click on Cerbios-Pharma at DCAT Week 2022  for venue information.


CERBIOS-PHARMA Company Brochure

Cerbios-Pharma returns to DCAT Week in NYC